- €601.33m
- €2.57bn
- €973.47m
- 45
- 73
- 81
- 78
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 709 | 767 | 935 | 949 | 973 |
Cost of Revenue | |||||
Gross Profit | 338 | 370 | 452 | 510 | 530 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 662 | 708 | 838 | 874 | 903 |
Operating Profit | 47.1 | 59.4 | 96.8 | 75.6 | 70.7 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 44.8 | 56.3 | 93.3 | 73.1 | 69 |
Provision for Income Taxes | |||||
Net Income After Taxes | 36.9 | 43.2 | 62.8 | 48.6 | 44.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 37.3 | 43.3 | 62.6 | 51.5 | 48.6 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 37.3 | 43.3 | 62.6 | 51.5 | 48.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.341 | 0.394 | 0.577 | 0.488 | 0.471 |
Dividends per Share |